You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukoencephalopathy, Progressive Multifocal

Showing 1 - 25 of 4,962
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Progressive Multifocal Leukoencephalopathy (PML)

Recruiting
  • Progressive Multifocal Leukoencephalopathy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

    Not yet recruiting
    • Multiple Sclerosis
    • Progressive Multifocal Leukoencephalopathy
    • 89 Zr-Df-crefmirlimab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

    Completed
    • Progressive Multifocal Leukoencephalopathy
    • PyVST
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

    Recruiting
    • Progressive Multifocal Leukoencephalopathy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 2, 2022

    Progressive Multifocal Leukoencephalopathy Trial (CE-VST01-JC)

    Not yet recruiting
    • Progressive Multifocal Leukoencephalopathy
    • CE-VST01-JC
    • (no location specified)
    Sep 14, 2022

    Progressive Multifocal Leukoencephalopathy Trial in France (Collection of blood and urine, Spinal tap, Brain MRI)

    Recruiting
    • Progressive Multifocal Leukoencephalopathy
    • Collection of blood and urine
    • +3 more
    • Bordeaux, France
    • +3 more
    Mar 15, 2022

    Multiple Sclerosis (MS) Registries

    Active, not recruiting
    • Progressive Multifocal Leukoencephalopathy
    • Tysabri
    • Cambridge, Massachusetts
      Research Site
    Mar 21, 2022

    HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Filgrastim, Cytarabine, Zidovudine)

    Completed
    • HIV Infections
    • Leukoencephalopathy, Progressive Multifocal
    • Aurora, Colorado
    • +8 more
    Oct 28, 2021

    Multiple Sclerosis Trial in Czechia (Natalizumab)

    Recruiting
    • Multiple Sclerosis
    • Brno, Czechia
    • +14 more
    Feb 2, 2022

    HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Cidofovir, Probenecid)

    Completed
    • HIV Infections
    • Leukoencephalopathy, Progressive Multifocal
    • Birmingham, Alabama
    • +18 more
    Oct 27, 2021

    Progressive Multifocal Leukoencephalopathy, AIDS Trial in Hangzhou (Pembrolizumab)

    Unknown status
    • Progressive Multifocal Leukoencephalopathy
    • AIDS
    • Hangzhou, Zhejiang, China
      the first affiliated hospital of Zhejiang university school of m
    Sep 18, 2019

    Myopia, Progressive Trial in New York, Toronto (Single vision contact lenses, Multifocal contact lenses)

    Recruiting
    • Myopia, Progressive
    • Single vision contact lenses
    • Multifocal contact lenses
    • New York, New York
    • +1 more
    Dec 2, 2021

    Myopia, Progressive Trial (orthokeratology lens, multifocal soft contact lens, Single vision spectacles)

    Not yet recruiting
    • Myopia, Progressive
    • orthokeratology lens
    • +2 more
    • (no location specified)
    Mar 6, 2023

    Do CCR5 Antagonists Improve Overall Survival of AIDS-related

    Completed
    • AIDS
    • Progressive Multifocal Leucoencephalopathy (PML)
    • Measure of overall survival
    • (no location specified)
    May 29, 2019

    Myopia, Progressive Trial in San Antonio (Proclear Single Vision Contact Lenses manufactured by CooperVision, Proclear

    Withdrawn
    • Myopia, Progressive
    • Proclear Single Vision Contact Lenses manufactured by CooperVision
    • Proclear Multifocal Contact Lenses manufactured by CooperVision
    • San Antonio, Texas
      Bowden Eye Care & Health Center
    Jul 3, 2022

    Inflammation in Progressive Multifocal Leukoencephalopathy (PML)

    Completed
    • Progressive Multifocal Leukoencephalopathy
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 26, 2019

      Crohn Disease Trial in Worldwide (Etrolizumab)

      Active, not recruiting
      • Crohn Disease
      • Arcadia, California
      • +291 more
      Nov 11, 2022

      Progressive Multifocal Intraocular Lens With Extended Depth of

      Completed
      • Cataract
      • Presbyopia
      • EDOF Mini WELL Ready IOL
      • Bari, Italy
        Azienda Ospedaliero Universitaria Consorziale Policlinico di Bar
      Mar 22, 2021

      Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

      Recruiting
      • Rare Disorders
      • +309 more
        • Sioux Falls, South Dakota
        • +1 more
        Jun 20, 2022

        A Post-Authorization, Long-term Study of Ozanimod Real-world

        Active, not recruiting
        • Multiple Sclerosis, Relapsing-Remitting
          • Bethesda, Maryland
            Evidera
          Oct 31, 2022

          Relapsing Remitting Multiple Sclerosis Trial in Netherlands (Personalized extended interval dosing of natalizumab, Standard

          Recruiting
          • Relapsing Remitting Multiple Sclerosis
          • Personalized extended interval dosing of natalizumab
          • Standard interval dosing
          • Almelo, Netherlands
          • +23 more
          Sep 22, 2021

          MS Had Greater Than 60 Infusions of Natalizumab

          Active, not recruiting
          • Multiple Sclerosis
          • Latham, New York
            Multiple Sclerosis Center of Northeastern New York, P.C.
          Mar 23, 2022

          Myopia, Myopia, Progressive Trial in San Bruno (NaturalVue Multifocal Contact Lens)

          Unknown status
          • Myopia
          • Myopia, Progressive
          • NaturalVue Multifocal Contact Lens
          • San Bruno, California
            Dr. Thomas Aller Optometrist, Inc.
          Jan 11, 2021

          Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))

          Recruiting
          • Multiple Sclerosis
          • Clermont-Ferrand, France
            CHU Clermont-Ferrand
          Jan 5, 2023

          Presbyopia Trial in Houston, Birmingham (Multifocal soft contact lenses, Progressive addition lens spectacles)

          Terminated
          Has Results
          • Presbyopia
          • Multifocal soft contact lenses
          • Progressive addition lens spectacles
          • Houston, Texas
          • +1 more
          Mar 10, 2020